المتحدثون

Dr. Walla Al Hertani

الدكتور خالد الخرازي

طبيب معالج أول، جراحة الأعصاب للأطفال، سدرة للطب

Dr. Abdelaziz Alsaman

Senior pediatric neurologist and neuromuscular consultant at King Fahad Medical City, Riyadh, Saudia Arabia. He completed his medical training at the College of Medicine in King Saud University, Saudia Arabia and attained his Arab and Saudi Boards in Pediatrics in 1998. He then went on to complete his Pediatric Neurology fellowship training at the Hospital for Sick Kids, University of Toronto, Canada, in 2003. Subsequently, he completed his neuromuscular fellowship at Hammersmith Hospital, Imperial College, UK, London, in 2008.

Prof. Dr. Roger Bayston

Dr. Roger Bayston trained at the University Faculty of Medicine in Sheffield, specializing in pathology and microbiology under Professor John Emery. He then studied surgical infection under Professor Robert Zachary and David Milner. He later moved to London where he was Senior Lecturer at the University of London and Microbiologist at The Hospital for Sick Children, Great Ormond Street and The National Hospital for Neurology and Neurosurgery, Queen Square. In 1993, he moved to the Faculty of Medicine at the University of Nottingham / Queen’s Medical Centre where he is now Professor Emeritus of Surgical Infection.

While in Sheffield he was awarded a national Research Fellowship, and his main research was into the causes of CSF shunt infections, which led to the first comprehensive case definition. He also developed a diagnostic serological test that led to a significant reduction in incidence of shunt nephritis, and in 1972 discovered the first “medical” biofilm – inside a shunt. Research into treatment of shunt infection led to a more efficient regimen with a significantly reduced hospital stay. Prof. Bayston is named inventor of an antimicrobial CSF shunt catheter now in worldwide use. In Nottingham, he has continued to develop next generation antimicrobial implants for shunting, external drainage and urinary catheterization and has written on infections in spinal instrumentation. He is the author of over 170 papers, one book and 15 book chapters.

Professor Bayston has been Hon Secretary, Hon Treasurer and President of the Society for Research into Hydrocephalus and Spina Bifida. He is a board member of a national charity concerned with people with hydrocephalus.

Dr. Tawfeg Ben-Omran

Dr. Ben-Omran has received his specialty training in clinical &metabolic genetics at the Hospital for Sick Children, University of Toronto, Canada. He has obtained both FRCPS & FCCMG in Medical Genetics in 2006. Currently, he is a senior consultant and Division Chief, Genetic and Genomic Medicine at Sidra Medicine. He is an Associate Professor at Weill Cornell Medical College, Qatar & New York-USA. He is also a Distinguished Visiting Scientist at Boston Children’s Hospital-USA.

He contributes to the body of published knowledge in clinical and metabolic genetics, with over 130 published articles in peer reviewed journals, book chapters and abstracts. He is reviewer for many clinical genetics journals.

He is an active clinical researcher, collaborating on projects with local, regional & international communities. He is a lead primary investigator in many high profile research projects & clinical trials to evaluate the long-term effects of enzyme replacement therapy in patients with different lysosomal storage disorders. Also a primary investigator in Nurture Trial for Spinal Muscular Atrophy. His main scientific interests include genetics of brain malformation & microcephaly, white matter disorders, dysmorphology, autosomal recessive disorders. In addition, Dr. Ben-Omran is an external advisor and expert for E-HOD (European registry and network for homocystinurias and methylation defects).

He is recognized as an expert in genetic disorders of the Arab population. His national & international presence is clear. He received Research Award from MRC-HMC for Homocystinuria project and Stars of Excellence Award 2011 for both Pioneering Newborn Screening & specialized care of Genetic Diseases in the Middle East. He has also awarded the Stars of Excellence in research 2014: Cutting Edge of Research in Medical Genetics.

He has memberships in many societies including: American Society of Human Genetics, European Society of Human Genetics, Society for the Study of Inborn Errors of Metabolism, Middle East Metabolic Genetic Group, the Middle East & North Africa Newborn Screening Initiative, Middle Eastern Lysosomal Storage Diseases Expert Council Advisory Board, Child Health Research Advisory Committee, International Society for Prenatal Diagnosis, Chairman of Middle East Metabolic Dieticians Group & Founder Member &Regional Representative of SSIEM Adult Metabolic Physicians Group.

الدكتورة ربى بنيني

المدير الطبي لمختبر التشخيص العصبي، سدرة للطب

الدكتورة ربى بنيني هي أخصائية أعصاب / صرع للأطفال. تشغل د. بنيني حالياً منصب المدير الطبي لمختبر التشخيص العصبي في سدرة للطب. وهي مديرة برنامج الزمالة في طب أعصاب الأطفال في سدرة، وتعمل كأستاذ مساعد في طب الأطفال السريري في طب وايل كورنيل، قطر. وهي زميلة الكلية الملكية للأطباء في كندا (FRCPC). حصلت الدكتورة بنيني على درجة الدكتوراه في علم الأعصاب عام 2006 من معهد مونتريال للأعصاب في كندا، كما حصلت على شهادتها في الطب عام 2008 من جامعة ماكجيل، مونتريال كندا، وأكملت تدريباً للإقامة في طب الأعصاب للأطفال عام 2014 في المركز الصحي بجامعة ماكجيل في مونتريال، وحصلت على زمالة في صرع الأطفال من مستشفى سانت جوستين، بجامعة مونتريال عام 2016. منذ ذلك الحين عملت كطبيبة أعصاب للأطفال وخبيرة في الصرع في مستشفى مونتريال للأطفال في مونتريال، ولاحقاً في مدينة الملك فهد الطبية (KFMC) في الرياض بالمملكة العربية السعودية، قبل أن تنضم إلى سدرة للطب في عام 2017. لدى د. بنيني اهتمام كبير بأبحاث الصرع لدى الأطفال، وهي تعمل في عدد من المشاريع البحثية التي تهدف إلى توضيح الجينات الوراثية لصرع الأطفال، مع الهدف النهائي المتمثل في تحسين حياة الأطفال المصابين بالصرع.

Dr. Michael Carter

سحر عيسى دعاس

تقود الدكتورة سحر دعاس مرفق دراسات الجينوم الوظيفية لأسماك الزرد في سدرة للطب، حيث تقدّم سلسلة من الاختبارات التي تعمل على سد الفجوة بين الأعراض السريرية وبين نتائج الأبحاث الجينومية. وتمثل هذه المنصة طريقة فحص سريعة ويمكن الاعتماد عليها للتحقق من الجينات المرشحة لأن تلعب دورًا في الأمراض السائدة في دولة قطر والاضطرابات الوراثية النادرة عند الأطفال.

بدأت الدكتورة دعاس مسيرتها البحثية بنمذجة الأمراض البشرية في مركز صحة IWK بكندا حيث عملت على دراسة الاضطرابات الوراثية النادرة والسرطانات في الأطفال. ويركز مجال اهتمامها البحثي على التحقق من أنماط الجينات الجديدة وتمييزها وكذلك الجينات التي يُحتمل أن يكون لها دور في اضطرابات النمو والاضطرابات العصبية لدى الأطفال. ويسلط عملها الضوء على أسماك الزرد باعتبارها نموذجًا تجريبيًا قيمًا يقدم خارطة طريق للسير نحو الطب الدقيق.

Prof. Dr. Luc De Catte

Dr. Luc De Cattehad his medical training at the Free University of Brussels and graduated in 1984, where after he was trained in OB-GYN receiving his certification in 1989. His primary focus was fetal-maternal medicine, and more particularly fetal medicine, fetal ultrasound and fetal therapy. In 2006, Dr. De Catte became associate professor at the Catholic University of Leuven, and Director of Fetal Maternal Medicine. His main interest is directed towards fetal brain anomalies, and congenital infections, in particular CMV. He is the author of over 140 international peer reviewed papers. Furthermore, he acts as the coordinator of the Interuniversity Training in Prenatal Ultrasound and Fetal Medicine.

Dr. Khalid Fakhro

Dr. Khalid A. Fakhro is the Chief Research Officer at Sidra Medicine and the Director of the healthcare facility’s Precision Medicine program. As the CRO for Sidra Medicine, Dr. Khalid Fakhro is responsible for designing and implementing the healthcare organization’s ambitious research strategy to advance precision medicine in Qatar. The strategy aims to place Sidra Medicine among the top destinations for personalized care in the world; leveraging next-generation technologies to enhance disease diagnosis and implement advanced therapies for patients.

Under Dr. Fakhro’s leadership, scientists in the Research Branch at Sidra Medicine, have made important strides to improve diagnosis of rare genetic conditions. They have also contributed towards Qatar’s efforts to tackle the COVID-19 pandemic, through the development of new testing methods and the publication of studies in conjunction with international collaborators.

Prior to being appointed as the CRO, he led the Human Genetics Department at Sidra Medicine and was the inaugural director of precision medicine, heading an ambitious program where research in genomics and personalized medicine become embedded in the heart of Sidra Medicine’s academic medical enterprise; with a focus on national priority conditions, such as genetic diseases, autism spectrum disorder, and diabetes.
Dr. Fakhro joined Sidra Medicine as a Principal Investigator in July 2014, and became Director of the Human Genetics department, where he built a robust genomic medicine research pipeline for the hospital.

Prior to joining Sidra Medicine, Dr. Fakhro was part of the Department of Genetic Medicine at Weill-Cornell Medicine in Qatar.
Dr. Fakhro graduated with Honors from the University of Chicago (USA) majoring in Biological Sciences with specialization in Cellular Biology and Molecular Genetics, and later completed his PhD in Human Genetics at Yale University (USA), where he was part of a highly selective HHMI Translational Medicine Scholars program, designed to train basic scientists to take discoveries from the bench to bedside.

Dr Fakhro is also involved in capacity building and education via adjunct faculty appointments at Weill-Cornell Medicine - Qatar and at Hamad bin Khalifa University, where he teaches classes and mentors the next generation of Masters and PhD students in human genetics and genomic medicine.

الدكتور محمود فوزي

طبيب معالج أول، طب أعصاب الأطفال، سدرة للطب

Dr. Francesca Fumagalli

Dr. Fumagalli started her clinical and scientific career as MD student in the Department of Neurology of San Raffaele Hospital, where she obtained her specialization in Neurology in 2009.

Since 2003 she acquired experience in adult general neurology and showing since the beginning a particular interest in inherited neurodegenerative collaborating with the outpatient service for Rare Neurological Disorders and San Raffaele Telethon Institute for Gene Therapy (SR-TIGET).

In 2004, she graduated at Vita-Salute San Raffaele University of Milan with a thesis entitled "Molecular, Neurophysiological and MRI study for the definition of nervous system damage caused by MLD. Prognostic and therapeutic implications”.

During the specialization, she cultivated her interest on the natural history of MLD taking care of affected patients and studying instrumental prognostic biomarkers, quantitative tools for monitoring disease progression and evaluating efficacy of innovative therapies. In 2016 she became the principal investigator of the prospective study on MLD Natural history ongoing at SR-TIGET resulting in two main publications (Biffi et al 2008 and Fumagalli et al 2021).

She dedicated her PhD (2010-2013) training in Paediatric Neurology at the Paediatric Unit of San Raffaele Hospital and collaborating to the phase I/II HSC Gene Therapy trial for MLD since 2010. Her responsibility was evaluating eligibility of MLD patients to gene therapy and monitoring neurological outcomes of patients enrolled in the clinical trial, resulting in her PhD thesis: “Preliminary demonstration of efficacy of lentiviral hematopoietic stem cell gene therapy in metachromatic leukodystrophy: analysis of neurological end-points” presented in the paper Biffi, Fumagalli et al. Science 2013 .

Between 2004 and 2013, she also learned skills in the field of Epilepsy as resident at the Neurophysiology Service of the Regional Centre for Epilepsy of San Raffaele Hospital (reading EEG recording and working at the outpatient service for Childhood Epilepsy).

Since 2013, she became Consultant Neurologist and then Staff Neurologist of the Department of Neurology and Paediatric Immunohematology Unit of San Raffaele Hospital in Milan, working as co-investigator of the gene therapy clinical trials on MLD and consultant Paediatric Neurologist of the Paediatric Unit. Moreover she collaborates to other Gene Therapy projects ongoing at SR-TIGET taking care of neurological aspects of other paediatric disorders (in particular ADA-SCID and MPS-IH).

Starting from February 2020, she also acted as an ad hoc consultant of Orchard Therapeutics and Takeda Advisory Boards.

Dr. Bajes Hamad

Dr. Bajes completed his Bachelor of Medicine and Surgery degree from University of Jordan and obtained his Pediatrics Specialist training at Hamad General Hospital Pediatric Nephrology section. He holds a Diplomat of the Arab Board of Pediatrics certification.

Dr. Bajes moved from HMC to Sidra Medicine as Senior Consultant bringing with him over 30 years of clinical experience and expertise in various areas of Pediatric Nephrology. He is currently the Director of Spina Bifida MDT at Sidra Medicine.

Aside from his clinical works, Dr. Bajes is an APLS and PLS instructor at HMC and an Assistant Professor of Clinical Pediatrics at Weill Cornell Medical College – Qatar.

Amongst his various committee membership were: Mortality and Morbidity Committee; Pediatrics Post Graduate Educational committee; Scientific Committee of the First Qatari International Pediatric Conference; Pediatric Track Scientific Committee, Qatar Health 2009. Dr. Bajes was also former Acting Pediatrics Department’s Representative at Supreme Council Committee for Treatment Abroad.

Dr. Bajes received the following honors and awards:

Best Specialist Physician in Pediatrics Department (HMC): 1988;

Best Publication Award (HMC) in 2005 as co-author of “Postnatal management of Antenatally Diagnosed Ureteropelvic Junction Obstruction, Journal of Pediatric Urology 2006”;

Certificate of "Stars of Excellence" 2010 as part of the Quality Improvement Team for his work with the Investigation Committees at HMC.

Dr. Cheryl Hemingway

Dr. Cheryl Hemingway has been a Consultant Paediatric Neurologist for 20 years. She has worked and trained in paediatric neurology at Red Cross Children’s Hospital, South Africa; Johns Hopkins, USA and in the UK, and has been a full time Neurology Consultant at Great Ormond Street Children’s Hospital (GOSH) from 2006. Her PhD from Imperial College, London used RNA microarray technology to explore the host immune response to brain inflammation and infection, and she has used the expertise gained from this to provide specialised clinical care to children with rare neuro-inflammatory disorders. She leads the GOSH Neuroinflammatory Disease service, the largest clinic in the UK for children with Multiple Sclerosis and other rare demyelinating and neuroinflammatory disorders. She is also research active, with a number of recent important publications and holds an MRC Clinical Academic Research Partnership Award. She is on the steering committee for the International Pediatric MS Study group and sits on a number of advisory panels for MS trial design.

الدكتور خالد إبراهيم

طبيب معالج أول، طب أعصاب الأطفال، سدرة للطب

الدكتور حسام كيالي

رئيس قسم طب أعصاب الأطفال، سدرة للطب

الدكتور حسام كيالي هو كبير أطباء أعصاب الأطفال، ومدير برنامج الصرع الشامل في سدرة للطب. تخرَّج الدكتور كيالي من جامعة حلب، وأنهى تدريبه في طب الأعصاب للأطفال في مستشفى ميرسي للأطفال في ميزوري، ثم أكمل برنامج الزمالة في الصرع والفيزيولوجيا العصبية السريرية في كليفلاند كلينيك في أوهايو.

الدكتور كيالي حاصل على شهادة البورد من المجلس الأميركي للطب النفسي والعصبي للأطفال، والفيزيولوجيا العصبية السريرية والصرع. قبل انضمامه إلى سدرة للطب عمل الدكتور كيالي أستاذاً مساعداً لأمراض الأعصاب لدى الأطفال في جامعة ميزوري - كنساس سيتي، وشارك في إنشاء مركز الصرع الشامل في مستشفى ميرسي للأطفال في ميزوري. انتقل بعد ذلك إلى مستشفى الملك فيصل التخصصي في المملكة العربية السعودية، حيث شغل منصب رئيس قسم أمراض الأعصاب لدى الأطفال، ومدير زمالة أعصاب الأطفال.

د. كيالي زميل جمعية الصرع الأميركية وعضو في الأكاديمية الأميركية لطب الأعصاب.

Prof. Dr. Martina Messing-Junger

Consultant in general neurosurgery with expertise in microsurgery, neurovascular and neuroendoscopy. She trained at the Düsseldorf University Medical School and completed her Neurosurgical training at the Düsseldorf University Hospital in 1994. She completed a subspecialization in Pediatric Neurosurgery and has been the head of Department of Pediatric Neurosurgery at Asklepios Children’s Hospital Sankt Augustin and director of the interdisciplinary surgical center since 2007. Prof. Dr. Martina Messing-Junger is the initiator and coordinator of the German Pediatric Neurosurgery Course (Section Pediatric Neurosurgery of the DGNC). She is an Associate Professor and lecturer at University of Düsseldorf University Medical School. She also serves as a member on multiple boards including: Executive Board of DGNC (German Neurosurgical Society), - German Academy of Neurosurgery (GANS, President 2022/2023), BDNC (German Neurosurgical Professional Board), ESPN (President 2016-2018), ISPN (Chair Liaison Committee), Scientific Board of the German Spina Bifida and Hydrocephalus Society (AsbH) and Scientific Board of the German Syringomyelia and Chiari Society (DSCM). She is also a reviewer and regional Editor of Scientific Journals and serves as a faculty of ESPN and ISPN courses.

Dr. Jaleel Miyan

Dr. Jaleel is a Neurobiology graduate of the University of Sussex, UK. He has remained a neuroscientist his entire career, receiving his PhD from the University of Glasgow in 1982. After 2 postdocs in Edinburgh and Sheffield, he was awarded a Royal Society University Research Fellowship which he held form 1986-96, initially at Edinburgh and then moved to Manchester where he is senior lecturer in neuroscience. His research has two themes, one is the connections between nerves and the host defence and immune system and, the second concerns the role of cerebrospinal fluid and cerebral folate metabolism in brain development, function and, more recently, in ageing. He has more than 100 publications, has prizes for teaching and research and, since Nov 2021, is President of the Society for Research in Hydrocephalus and Spina Bifida. Current research aims are to translate a treatment that prevents hydrocephalus into human use as well as working on extending the cerebral folate hypothesis to other conditions affecting the cerebral cortex.

الدكتور يونس مقراب

الدكتور يونس مقراب هو أخصائي علم الوراثة والمعلومات الحيوية ويعمل حاليًا كباحث رئيسي ورئيس مختبر الجينوميات الطبية والسكانية في سدرة للطب ، قطر ، وهو أيضًا أستاذ مساعد في الطب الوراثي في كلية وايل كورنيل للطب.

حصل الدكتور مقراب على درجة بكالوريوس العلوم الطبية في علم الوراثة من جامعة شيفيلد بالمملكة المتحدة عام ٢٠٠٣ ، وعلى درجة الدكتوراه في المعلومات الحيوية من جامعة كامبريدج عام ٢٠٠٧ ، ثم أجرى دراسات ما بعد الدكتوراه في جامعة أكسفورد عام ٢٠١٠. بعد ذلك عمل فيمجال المستحضرات الصيدلانية ، في البداية مع شركة لونزا بيولوجيكز وفي وقت لاحق قسم استكشاف علم الأعصاب في شركة إيلي ليلي وأثناء هذه الفترة أصبح مشاركًا فعالًا في اتحاد علم الجينوم النفسي.وينصب اهتمام مجموعته البحثية حاليًا على استخدام التقنيات الجينومية المتقدمة لدراسة نوبات الصرع واضطرابات النمو العصبي ، كجزء من علاقات التعاون المحلية والدولية.ويعمل مختبره كذلك على استكشاف البنية السكانية البشرية على نحودقيق وعلاقتها بالبنية الجينية للأمراض وعوامل الخطر المسببة لها، لا سيما بين فئة الأقارب من الشرق الأوسط. وهو عضو مؤسس في اتحاد أبحاث برنامج قطر جينوم. الدكتور مقراب حائز على العديد من المنح البحثية المحلية والدولية وألف أكثر من 55 مقالًا بالإضافة إلى كونه محررًا ومراجعًا للعديد من المجلات البارزة.

الدكتور إيان بوبل

رئيس قسم جراحة المخ والأعصاب للأطفال، سدرة للطب

حصل ايان على شهادة الطب من جامعة شيفيلد بالمملكة المتحدة، وتلقى تدريبه في جراحة الأعصاب في ليدز بلندن (مستشفى غريت أورموند ستريت) وبريستول، قبل حصوله على زمالة في جراحة أعصاب الأطفال في مستشفى لو بونور للأطفال، ومستشفى سانت جود لأبحاث الأطفال في ممفيس بالولايات المتحدة الأميركية. بدأ بممارسة جراحة الأعصاب منذ عام 1995 في بريستول بالمملكة المتحدة في مستشفى فرينشاي ومستشفى ساوثميد ومستشفى بريستول الملكي للأطفال.

تتركز اهتمامات ايان البحثية بشكل أساسي على علاج استسقاء الرأس لدى الأطفال، بما في ذلك الأطفال حديثي الولادة، وإصابات الرأس، وتشوهات الحبل الشوكي، ومعالجة تشنج الأطراف السفلية. لديه أكثر من 65 منشوراً طبياً تمت مراجعتها من قِبل الزملاء، ولديه اهتمام بحثي نشط يدعم المشاريع الحديثة على الصعيدين المحلي والدولي.

تشمل رؤية ايان لخدمات جراحة المخ والأعصاب للأطفال في قطر تطوير خدمة جراحة الأعصاب الطارئة الآمنة والمستدامة، والتي تتجاوز الحد الأدنى من المعايير المنصوص عليها في تقييمات الأعصاب والصدمات التي أجرتها الخدمات الصحية الوطنية البريطانية NHS مؤخراً في المملكة المتحدة، مع إعداد برامج جراحية عالمية المستوى في جراحة الصرع والتشنج عند الأطفال لعلاج تشنج الأطراف السفلية. كما يساعد في تطوير ودعم العناصر السريرية والبحثية للخدمات الهامة الأخرى مثل خدمات علاج الأورام القحفية والعمود الفقري والأورام العصبية.

Dr. Will Singleton

Dr. Will Singleton is a consultant pediatric neurosurgeon at Bristol Royal Hospital for Children, honorary senior lecturer at the University of Bristol, UK. He trained in Oxford, Plymouth and Bristol, UK and undertook a fellowship in pediatric neurosurgery at Sick Kids, University of Toronto, Canada He was awarded the Norman Dott Gold Medal from the Society of British Neurosurgeons in 2019 for the highest national score in the intercollegiate fellowship of the royal colleges of surgeons (FRCS) professional examination. He is a part of the steering group of the international Children’s Brain Tumour Drug Delivery Consortium (CBTDDC.org) and the Treasurer elect of the Society for research into Hydrocephalus and Spina Bifida (SRHSB.com).

Dr. Singleton has clinical interests in paediatric functional neurosurgery and its application to epilepsy surgery, neonatal neurosurgery, the dysraphic spine, hydrocephalus and paediatric neurooncology. I have research interests in central nervous system drug delivery, the application of advanced stereotactic techniques to paediatrics, and the translation of novel neurosurgical techniques from the laboratory.

Dr. Santiago Vallasciani

Dr. Santiago Vallasciani joined Sidra in January 2018 as Senior Attending Physician. He was formerly the Chief of Pediatric Urology Division in King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia. After his graduation in the Medical School in Argentina, Dr Vallasciani moved to Italy where he developed his career in Pediatric Urology as subspecialty of Pediatric Surgery. He has a special interest in Genito-Urinary reconstruction and Minimally invasive surgery. Dr Vallasciani published over 50 papers in peer-reviewed journals and more than 100 congress abstracts. His interest covers also research either clinical, basic and public health and received international awards for that. Medical Education is another of his interests with Faculty position in Al Faisal University in Riyadh and currently as Assistant Director of the Pediatric Urology Fellowship in Sidra.

He is active internationally with participation as invited speaker in meetings and visiting surgeon

مؤتمر علم الأعصاب للأطفال 2022

بالتعاون مع الجمعية البحث في استسقاء الرأس وتشوهات الحبل الشوكي

Add to Calendar

اللجنة المنظّمة/مديرو الجلسات

الدكتورة ربى بنيني

الدكتور حسام كيالي

الدكتور إيان بوبل

لجنة التخطيط العلمي

الدكتور خالد الخرازي

الدكتورة ربى بنيني

الدكتور محمود فوزي

الدكتور خالد إبراهيم

الدكتور حسام كيالي

الدكتور إيان بوبل

الدكتور خالد زامل

Dr. Walla Al Hertani

الدكتور خالد الخرازي

Dr. Abdelaziz Alsaman

Prof. Dr. Roger Bayston

Dr. Tawfeg Ben-Omran

الدكتورة ربى بنيني

Dr. Michael Carter

سحر عيسى دعاس

Prof. Dr. Luc De Catte

Dr. Khalid Fakhro

الدكتور محمود فوزي

Dr. Francesca Fumagalli

Dr. Bajes Hamad

Dr. Cheryl Hemingway

الدكتور خالد إبراهيم

الدكتور حسام كيالي

Prof. Dr. Martina Messing-Junger

Dr. Jaleel Miyan

الدكتور يونس مقراب

الدكتور إيان بوبل

Dr. Will Singleton

Dr. Santiago Vallasciani

الدكتور خالد زامل